Sign in

CIK 0001093557 · Large accelerated filer

DEXCOM INC

Sign in to watch
Ticker
DXCM
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
330857544
Phone
8582000200
Business address
6340 SEQUENCE DRIVE, SAN DIEGO, CA, 92121
  1. 4 Grant or award SVP Chief Information Officer acquired 10,885 shares (grant or award)
  2. 4 Grant or award EVP Chief Human Resources Offi acquired 21,769 shares (grant or award)
  3. 4 Grant or award EVP Chief Financial Officer acquired 21,769 shares (grant or award)
  4. 4 Open-market sale EVP Chief Technology Officer sold 18,144 shares at an average $114.74 ($2,081,822)
  5. 4 Open-market sale SVP Corporate Strategy-Develop sold 226 shares at $114.40 ($25,854)
  6. 4 Open-market sale President CEO and Chairman of sold 38,464 shares at an average $109.94 ($4,228,611)
  7. 4 Open-market sale EVP Managing Director Dexcom V sold 412 shares at $111.64 ($45,996)
  8. 4 Open-market sale EVP Chief Financial Officer sold 2,400 shares at $114.54 ($274,896)
  9. SC 13G/A Stake Amended Statement of Ownership
  10. 10-K Report Annual Report
  11. 8-K Event Results of operations
  12. SC 13G/A Stake Amended Statement of Ownership
  13. 4 Open-market sale EVP Operations sold 2,213 shares at $106.12 ($234,844)
  14. 4 Open-market sale President CEO and Chairman of sold 56,844 shares at an average $106.15 ($6,034,123)
  15. SC 13G/A Stake Amended Statement of Ownership
  16. SC 13G/A Stake Amended Statement of Ownership
  17. 4 Open-market sale President CEO and Chairman of sold 45,607 shares at $105.75 ($4,822,872)
  18. 4 Open-market sale EVP Managing Director Dexcom V sold 412 shares at $107.86 ($44,438)
  19. 4 Grant or award President CEO and Chairman of acquired 90,720 shares (grant or award)
  20. 3 Insider Initial Statement of Ownership

Page 24 of 133 · 2,656 filings